# J&J has halved the time needed to identify promising new drug candidates.

*biotech · news · 2026-04-27 · The Economic Times*

## Key points

- Johnson & Johnson has halved the time needed to identify promising new drug candidates using AI.
- AI has reduced the time for preparing clinical trial regulatory reports from 700 hours to 15 minutes.
- J&J is applying AI to optimize manufacturing, such as precisely timing solvent additions.
- AI implementation is expanding, not replacing, existing IT roles at Johnson & Johnson.

**Companies:** Johnson & Johnson
**Countries:** United States

[Read the full story on The Economic Times](https://economictimes.indiatimes.com/tech/artificial-intelligence/jj-sees-ai-halving-the-time-to-generate-drug-development-leads/articleshow/130558501.cms)

---

Canonical: https://newsio.io/n/c402e9b3-b01b-48b4-be39-23b6a0314a1c/jj-has-halved-the-time-needed-to-identify-promising-new-drug-candidates-ai-is-al
Summarized by Newsio from The Economic Times. https://newsio.io/how-it-works